Penicillamine-induced elastosis of the mucosal lip

Journal of the American Academy of Dermatology

Volumn 60, Issue 4, 2009, Pages 700-703

  Lewis, Bethany K H ^a,b   Chern, Peggy L ^c   Stone, Mary Seabury ^b,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; PENICILLAMINE; TAZAROTENE; TRIENTINE; ZINC ACETATE;

ADD ON THERAPY; ADULT; ARTICLE; AXILLA; CASE REPORT; COPPER BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELASTOSIS; ELASTOSIS PERFORANS SERPIGINOSA; HUMAN; HUMAN TISSUE; LIP; MALE; MUCOSA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN BIOPSY; TREATMENT RESPONSE; WILSON DISEASE;

CHELATING AGENTS; HUMANS; LIP DISEASES; MALE; MIDDLE AGED; MOUTH MUCOSA; PENICILLAMINE;

EID: 61849126799     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.09.018     Document Type: Article

References (17)

1. Becuwe C., Dalle S., Ronger-Salve S., Skowron F., Balme B., Kanitakis J., et al. Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson's disease with penicillamine. Dermatology 210 (2005) 60-63
2. Poon E., Mason G.H., and Oh C. Clinical and histological spectrum of elastotic changes induced by penicillamine. Australas J Dermatol 43 (2002) 147-151
3. Hill V.A., Seymour C.A., and Mortimer P.S. Penicillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson's disease. Br J Dermatol 142 (2000) 560-561
4. Blasberg B., Dorey J.L., Stein H.B., Chalmers A., and Conklin R.J. Lichenoid lesions of the oral mucosa in rheumatoid arthritis patients treated with pencillamine. J Rheumatol 11 (1984) 348-351
5. Pass F., Goldfischer S., Sternlieb I., and Scheinberg H. Elastosis perforans serpiginosa during penicillamine therapy for Wilson disease. Arch Dermatol 108 (1973) 713-715
6. Lewis K.G., Bercovitch L., Dill S.W., and Robinson-Bostom L. Acquired disorders of elastic tissue, part I: increased elastic tissue and solar elastotic syndromes. J Am Acad Dermatol 51 (2004) 1-21
7. Dalziel K.L., Burge S.M., Frith P.A., Ryan T.J., and Mowat A. Elastic fiber damage induced by low-dose penicillamine. Br J Dermatol 123 (1990) 305-312
8. Babu Manohar M., Boldy D.A.R., Bryan R.L., Path M.R.C., and Pearman K. Penicillamine-induced changes in elastic tissue of the upper respiratory tract. J Laryngol Otol 107 (1993) 62-64
9. Bardach H., Gebhart W., and Niebauer G. "Lumpy-bumpy" elastic fibers in the skin and lungs of a patient with penicillamine-induced elastosis perforans serpiginosa. J Cutan Pathol 6 (1979) 243-252
10. Burge S., and Ryan T. Penicillamine-induced pseudo-pseudoxanthoma elasticum in a patient with rheumatoid arthritis. Clin Exp Dermatol 13 (1988) 255-258
11. Meyrick Thomas R.H., and Kirby J.D.T. Elastosis perforans serpiginosa and pseudoxanthoma elasticum-like skin change due to D-penicillamine. Clin Exp Dermatol 10 (1985) 386-391
12. Amichai B., Rotem A., and Metzker A. D-penicillamine-induced elastosis perforans serpiginosa and localized cutis laxa in a patient with Wilson's disease. Isr J Med Sci 30 (1994) 667-669
13. Kirsch N., and Hukill P.B. Elastosis perforans serpiginosa induced by penicillamine: electron microscopic observations. Arch Dermatol 113 (1977) 630-635
14. Reymond J.L., Stoebner P., Zambelli P., Beani J.C., and Amblard P. Penicillamine induced elastosis perforans serpiginosa: an ultrastructural study of two cases. J Cutan Pathol 9 (1982) 352-357
15. Price R.G., and Prentice R.S.A. Penicillamine-induced elastosis perforans serpiginosa: tip of the iceberg?. Am J Dermatopathol 8 (1986) 314-320
16. Outland J.D., Brown T.S., and Callen J.P. Tazarotene is an effective therapy for elastosis perforans0 serpiginosa. Arch Dermatol 138 (2002) 169-171
17. Kelly S.C., and Purcell S.M. Imiquimod therapy for elastosis perforans serpiginosa. Arch Dermatol 142 (2006) 829-830